Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Neurofibromatosis 1 × Lamotrigine × Clear all

Phase

Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02256124 2020-04-14

NF1-EXCEL

Erasmus Medical Center

Phase 2/3 Terminated

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡